首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Fiber-substituted Conditionally Replicating Adenovirus for Oncolysis of Human Renal Carcinoma Cells.
【24h】

Fiber-substituted Conditionally Replicating Adenovirus for Oncolysis of Human Renal Carcinoma Cells.

机译:纤维取代的条件复制腺病毒对人肾癌细胞的溶瘤作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Adenovirus vectors have lately been highlighted in gene therapies. We investigated the oncolytic effects of a chimeric adenovirus type 5 (Ad5) with replacement of Ad5 fiber knob with adenovirus type 35 (Ad35) fiber knob (Ad5F35) on human renal cell carcinoma (RCC).The conditionally replicating Ad5F35 vector was constructed and infected into RCC cell lines 786-O, ACHN, and RCC4-VHL. For these cells, reverse transcription-polymerase chain reaction and western blotting were carried out and the cell viability was assayed.In all RCC cell lines, it was found that CD46, a cell surface target of Ad35, was well-expressed, while coxsackie and adenovirus receptor (CAR), a cell surface target of Ad5, was considerably less expressed. The Ad5F35 vector induced oncolysis of RCC cells, with significantly higher efficacy as compared with that for the Ad5 vector.Ad5F35 vector could be a candidate for promising gene therapy of human RCC.
机译:腺病毒载体近来已在基因疗法中被强调。我们研究了一种嵌合型5型腺病毒(Ad5)用35型腺病毒(Ad35)纤维瘤(Ad5F35)替代Ad5纤维瘤对人肾细胞癌(RCC)的溶瘤作用。条件复制的Ad5F35载体的构建和感染进入RCC细胞系786-O,ACHN和RCC4-VHL。对于这些细胞,进行了逆转录-聚合酶链反应和蛋白质印迹,并测定了细胞活力。在所有RCC细胞系中,发现CD46是Ad35的细胞表面靶标,表达良好,而柯萨奇和腺病毒受体(CAR)是Ad5的细胞表面靶标,其表达明显较低。与Ad5载体相比,Ad5F35载体能诱导RCC细胞发生溶瘤作用。Ad5F35载体可能是人类RCC基因治疗的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号